Abstract:Objective Myostatin (MSTN) is a member of the TGF-β superfamily and is a negative regulator of skeletal muscle growth. MSTN is also expressed in other tissues such as heart and fat. The purpose of this study was to elucidate the occurrence of myocardial IR caused by myocardial MSTN expression, and to elucidate the regulation of MSTN expression by exercise and improve myocardial IR status and myocardial interstitial fibrosis. Methods The literatures on exercise, myocardial IR, and myocardial MSTN published in recent years were reviewed and summarized. Results 1.Myostatin, which is rarely expressed in myocardium under normal conditions, the appropriate amount of MSTN expression has anti-cardiac hypertrophy, and excessive MSTN expression can cause various cardiovascular diseases. In the IR state, the expression of myocardial inflammatory factors is increased, and MSTN is highly expressed. MSTN acts on the myocardium through various pathways, leading to the occurrence of myocardial fibrosis. In the IR state, possible pathways for inducing high expression of MSTN include: (1) inflammatory factor TNF-α is elevated, and MSTN expression is induced by P38MAPK and NF-KB; (2) The transcription factor Smad-2/3/4 up-regulates the MSTN promoter activity; (3) Glucocorticoid up-regulates MSTN expression; (4) IGF-1 up-regulates MSTN expression via p38MAPK and transcription factor MEF-2; (5) AngII up-regulates MSTN via Ang1 receptor, p38MAPK and MEF-2;(6) urotensin-II and urocortin can stimulate MSTN expression;(7) The ERK-1/2-MEF-2 pathway up-regulates MSTN expression. 3. Possible pathways by which MSTN acts on the myocardium include:(1) MSTN induces Smad2/3 overexpression; (2) MSTN activates the NF-KB pathway; (3) MSTN activates miR-1 expression, inhibits HSP70, and decreases pAkt levels; (4) MSTN inhibits the PI3K-Akt pathway, leading to induction or damage of the downstream pathway. Regular endurance exercise and resistance exercise improve myocardial IR and myocardial interstitial fibrosis involved in MSTN. This effect is mainly dependent on exercise can effectively improve the body's chronic inflammatory state, down-regulate the MSTN superior inducer, resulting in a series of cascade reactions. Conclusions 1.MSTN expression in myocardial tissue is dose-dependent,proper expression of MSTN in the myocardium can prevent cardiac hypertrophy, and overexpression of MSTN can lead to various cardiovascular diseases. 2.Under the hyperglycemia and inflammation state, it can induce high expression of MSTN. After high expression of myocardial MSTN, it can participate in myocardial IR and can lead to myocardial interstitial fibrosis. 3. Exercise can effectively improve the chronic inflammatory state of the body, down-regulate the level of MSTN induction, improve myocardial IR status and IR-induced myocardial interstitial fibrosis.

Myostatin: a potential therapeutic target for metabolic syndrome

Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle.

Myostatin regulates energy homeostasis through autocrine- and paracrine-mediated microenvironment communication

Myostatin: a novel insight into its role in metabolism, signal pathways, and expression regulation.

Myokines: Metabolic Regulation in Obesity and Type 2 Diabetes

Novel Roles of Follistatin/Myostatin in Transforming Growth Factor-β Signaling and Adipose Browning: Potential for Therapeutic Intervention in Obesity Related Metabolic Disorders

The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy

Circulating Mir-143-3p Inhibition Protects Against Insulin Resistance in Metabolic Syndrome Via Targeting of the Insulin-Like Growth Factor 2 Receptor.

Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach

Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions

Inhibiting Myostatin Signaling Prevents Femoral Trabecular Bone Loss and Microarchitecture Deterioration in Diet-Induced Obese Rats

Regulation of Myostatin on the Growth and Development of Skeletal Muscle

Proteomics Insights into the Effects of MSTN on Muscle Glucose and Lipid Metabolism in Genetically Edited Cattle

The function of myostatin in the regulation of fat mass in mammals

A New Insight into the Roles of MiRNAs in Metabolic Syndrome

Myostatin Knockout Affects Mitochondrial Function by Inhibiting the AMPK/SIRT1/PGC1α Pathway in Skeletal Muscle

Myostatin regulates fatty acid desaturation and fat deposition through MEF2C/miR222/SCD5 cascade in pigs

PO-273 Exercise, Myocardial Insulin Resistance and Myostatin

Loss of Myostatin Alters Mitochondrial Oxidative Phosphorylation, TCA Cycle Activity, and ATP Production in Skeletal Muscle.

Myostatin Deficiency Enhances Antioxidant Capacity of Bovine Muscle Via the SMAD-AMPK-G6PD Pathway.

Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome